Skip to content
229,518 profiles ranked

No free photograph

Mojisola Adeyeye

Pharmacist and government official · Nigeria · On the map · Academics

Mojisola Christianah Adeyeye is a Nigerian pharmacist and professor. She was appointed the Director-General of National Agency for Food and Drug Administration and Control (NAFDAC) on 3 November 2017 by the President of The Federal Republic of Nigeria, Muhammadu Buhari.

Mojisola Adeyeye is read about 20 times a day, in 9 languages.

A typical day, 30 days to 28 October 2026

The middle day of the days counted, so one week of news cannot move it. The line under it is the last 96 days, one point a day.

Something wrong?
Compare Claim

People around Mojisola

Family

Mojisola Adeyeye

Partners

Is this everyone?

Only relatives with a profile here are drawn, so a family can be larger than this. A line here can also be wrong. A marriage is drawn as ended only where its end is recorded, so a spouse drawn here may be a former one.

Correct this family

Awards

Fellow of the Nigerian Academy of Science2016

About this person

Before her appointment as NAFDAC boss, she was the founding Chair of Biopharmaceutical Sciences and a Professor of Pharmaceutics, Manufacturing Science and Drug Product Evaluation at the College of Pharmacy, Roosevelt University in Schaumburg, Illinois, where she spent 7 years. She was also a Professor of Pharmaceutics and Manufacturing for 21 years at Duquesne University in Pittsburgh, Pennsylvania, USA. She is Senior Fulbright Scholar and Specialist and 2008 American Association of Pharmaceutical Scientists Fellow. She is also a Fellow of the Nigerian Academy of Science and Nigeria Academy of Pharmacy. Her research interests are in the areas of pre-formulation, early phase development of solid, semisolid and liquid dosage forms, and IND-based and intellectual property-driven late phase drug product development. She is the founder and President of Elim Pediatric Pharmaceuticals Rolling Meadows, Illinois. Through Duquesne University, she was able to develop an anti-retroviral (HIV/AIDS) pediatric fixed-dose combination and received intellectual property on the formulations in the UK and South Africa.

Country
Nigeria
Category
Academics
Type
Academic